这家做癌症医药研究的，成立于1999年，去年只有300万美元，IPO打算融资5000万美元，你敢把钱投给这公司吗？ Cancer Genetics, which offers proprietary genomic tests to improve the diagnosis, prognosis and treatment of cancer, filed on Friday with the SEC to raise up to $50 million in an initial public offering. The Rutherford, NJ-based company, which was founded in 1999, booked $3 million in sales for the 12 months ended September 30, 2011. Cancer Genetics plans to list on the NASDAQ under the symbol CGIX. William Blair and Baird are the lead underwriters on the deal, for which pricing terms and timing were not disclosed